Wnt/β-Catenin-Pathway Alterations and Homologous Recombination Deficiency in Cholangiocarcinoma Cell Lines and Clinical Samples: Towards Specific Vulnerabilities
Alexander Scheiter(University of Regensburg), Kirsten Utpatel(University of Regensburg)
Cited by 7
Related Papers
Inhibition of MELK Protooncogene as an Innovative Treatment for Intrahepatic Cholangiocarcinoma
|Medicina|2019|13
RASSF1A independence and early Galectin-1 upregulation in PIK3CA induced hepatocarcinogenesis: new therapeutic venues
|bioRxiv (Cold Spring Harbor Laboratory)|2021|1